Val Giddings' presentation on a panel at the Society for Benefit Cost Analysis meeting argues that regulatory disincentives to innovation in agricultural biotechnology can be reduced by a return to fundamental principals of risk assessment and management, as longstanding U.S. Policy requires.
From a skewed standardization law in China to mercantilist digital services tax proposals in Europe, when countries impose protectionist policies in high-value, high-tech sectors, they don’t just damage competitors; they damage the entire global innovation system.
If countries do not show proper restraint, they can easily sabotage the global Internet by imposing unreasonable obligations on companies and setting up scenarios where companies are forced into a no-win situation of having to comply with conflicting laws.
A brief recap of some of the biggest developments and surprises in agricultural biotechnology innovation in 2018.
The next wave of digital innovation is coming. Countries can welcome it, prepare for it, and ride it to new heights of innovation and prosperity, or they can ignore the changing tide and miss the wave.
Rob Atkinson spoke on a panel at the 2018 G7 Multistakeholder Conference on Artificial Intelligence in Montréal, Canada.
There are nearly 6,000 firms with revenues exceeding $1 billion, representing nearly two-thirds of global corporate earnings. The 10 percent of those firms with the largest profits produce 80 percent of the group’s total earnings. A new study has found that firms in the top 1 percent outperform the median firm across the board, with 20 times more revenue, 12 times more employees, 2.9 times more R&D intensity, 23 percent more labor productivity, and 14 percent more fixed capital productivity.
Gene editing is a process of making precise changes to an organism’s DNA in a manner analogous to the way we change the text of a document with word processing software.
The Non-GMO Project food label deliberately deceives and misleads consumers in violation of the Federal Food, Drug and Cosmetic Act. ITIF petitions FDA to prohibit such labels.
ITIF submitted comments to the USDA Agriculture Marketing Service's proposed regulations to implement the National Bioengineered Food Disclosure Standard, aka "GMO" labeling.
ITIF hosted a discussion with author Mark Zachary Taylor to better understand the politics of innovation and the implications for the United States.
If drug price controls were lifted throughout the OECD, the number of new treatments available would increase 8 to 13 new drug compounds by 2030, writes John Wu in Innovation Files.
While website blocking was never going to be the silver bullet to solve piracy online, this was never the goal, merely that it be one of the many tools in the toolbox that countries can use to fight piracy and improve the market for legal content online writes Nigel Cory in Innovation Files.
The Global Trade and Innovation Policy Alliance will be hosting its 2018 summit of world-leading thinkers discussing new approaches toward trade, innovation, and globalization for the benefit of the international community and economy in Milan, Italy.
Foreign predatory economic practices harm the U.S. economy. In testimony before a Senate Foreign Relations subcommittee, Rob Atkinson outlines how the U.S. government should respond.
Nigel Cory discussed cross-border data flows during a panel at George Mason University’s Eighth Annual Public Policy Institute on Financial Services.
Intellectual property rights go a long way to helping transform clever ideas into life-saving products that address global health challenges, ITIF’s Stephen Ezell and Mark Schultz of the Southern Illinois University School of Law write for Brink News.
Twenty-five case studies underscore how innovators in developing countries—often enabled by robust IP rights—are achieving advances in life sciences and healthcare that benefit people around the world.
Please join ITIF and the Center for the Protection of Intellectual Property for an event releasing a new report that documents 25 cases of primarily developing-world entrepreneurs meeting global health challenges by “innovating for health.” The event will discuss what policies, including intellectual property, are needed to underpin successful life-sciences innovation in both the developed and developing world and feature presentations from several developing-country healthcare innovators who are leveraging IP, science, and technology to create a better world.
The digitalization of manufacturing is changing how products are designed, fabricated, used, and serviced, just as it’s transforming the operations, processes, and energy footprint of factories and supply chains.
It is imperative that the United States do more to identify, analyze, and respond to the growing number of countries which are enacting unfair and discriminatory policies that target U.S. ICT firms. The U.S.’s position as a world leader in many high-tech sectors will be undermined if these modern trade barriers continue to spread.
GMOs can save civilization by addressing the major challenges of food security, carbon emissions, and environmental stewardship in a way that benefits farmers, consumers, and biodiversity writes Val Giddings in Innovation Files.
The lack of alternative diagnostic options has become a major roadblock to getting more people with HIV on the path to treatment. But an innovative new product may finally do this.
Adding 10 more bank branches per 100,000 adults in developing economies increases the probability that businesses will invest in R&D by 7.6 percent, writes John Wu in Innovation Files.
Speaking in São Paulo, Brazil, to an audience of Senate, Chamber of Deputies, and Court technical staff, Rob Atkinson outlined the keys to digital trade success and explained that a growing number of companies in various industries are relying on cross border data flows.